Search

Search Results
Results 5061 - 5070 of 6263 for Abdominal
  • Opdivo SC
    Drug - 19 Dec 2025
    Consumer Medicine Information (CMI) about Opdivo SC intended for persons living in Australia.
  • Chrononutrition Explained: Why When You Eat Matters for Metabolic Health
    Health - 16 Dec 2025
    Chrononutrition research indicates that eating later in the evening or at night, when circadian physiology is less favorable for glucose handling, can worsen postprandial metabolism and, over time,...
  • They need a ventilator to stay alive. Getting one can be a nightmare.
    News - 2 Dec 2025
    On vacation in Mexico last year, Michael DiPlacido passed out twice while scuba diving and again in his hotel. Back in St. Louis, doctors diagnosed him with amyotrophic lateral sclerosis, or ALS, an...
  • GlucaGen Hypokit
    Drug - 20 Nov 2025
    Consumer Medicine Information (CMI) about GlucaGen Hypokit intended for persons living in Australia.
  • Menopur
    Drug - 13 Nov 2025
    Consumer Medicine Information (CMI) about Menopur intended for persons living in Australia.
  • Personalized prehabilitation reduces the risk of surgical complications
    News - 12 Nov 2025
    The weeks leading up to a major surgery can be a time of uncertainty and worry for patients, many of whom anticipate the need for rehabilition to get back on their feet.
  • New data supports earlier use of evolocumab in high-risk diabetes
    News - 11 Nov 2025
    Adding the PCSK9 inhibitor evolocumab to a high-intensity, cholesterol-lowering regimen reduced the risk of a first major cardiovascular event among adults with atherosclerotic cardiovascular disease...
  • Mylotarg
    Drug - 10 Nov 2025
    Consumer Medicine Information (CMI) about Mylotarg intended for persons living in Australia.
  • Advances in diagnosis and management of systemic light chain amyloidosis
    News - 30 Oct 2025
    Systemic light chain (AL) amyloidosis is a rare and life-threatening disorder characterized by the deposition of misfolded immunoglobulin light chains as insoluble amyloid fibrils in various tissues...
  • Mayne Pharma Oxycodone IR
    Drug - 28 Oct 2025
    Consumer Medicine Information (CMI) about Mayne Pharma Oxycodone IR intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback